SCHEMBL16892154

SCHEMBL16892154

Cc1ccc(Oc2cc(N)cc(F)c2)cc1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.42
SMN1; SMN2 Q16637 4/20 0.42
MEN1 O00255 5/20 0.40
KMT2A Q03164 5/20 0.40
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
NLRP3 Q96P20 1/20 0.39
F2 P00734 1/20 0.37
PRSS1 P07477 1/20 0.37
PRSS2 P07478 1/20 0.37
PRSS3 P35030 1/20 0.37
ST14 Q9Y5Y6 1/20 0.37
TEAD4 Q15561 1/20 0.36
MAPT P10636 5/20 0.36
HPGD P15428 1/20 0.36
POLB P06746 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
MITF O75030 1/20 0.35
GAA P10253 1/20 0.35
GFER P55789 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8999880 0.82 MEN1 (0.53) ALDH1A1SMN1; SMN2MEN1KMT2ANPC1
SCHEMBL19792025 0.81 MAOB (0.56) ALDH1A1SMN1; SMN2MEN1KMT2ANPC1
SCHEMBL16892153 0.81 TEAD4 (0.59) ALDH1A1SMN1; SMN2MEN1KMT2ANPC1
SCHEMBL8999877 0.80 MEN1 (0.43) ALDH1A1SMN1; SMN2MEN1KMT2ANPC1
SCHEMBL22693618 0.78 MEN1 (0.50) ALDH1A1SMN1; SMN2MEN1KMT2ANPC1
SCHEMBL1100004 0.78 MEN1 (0.47) ALDH1A1SMN1; SMN2MEN1KMT2ANPC1
SCHEMBL10269468 0.77 FFAR1 (0.43) ALDH1A1MRGPRX4
SCHEMBL1100256 0.77 ALDH1A1 (0.55) ALDH1A1SMN1; SMN2MEN1KMT2ANPC1
SCHEMBL257852 0.76 SOS1 (0.50) SMN1; SMN2MEN1KMT2AMAPTHPGD
SCHEMBL257919 0.74 TEAD4 (0.48) ALDH1A1SMN1; SMN2MEN1KMT2ATEAD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150191473-A1 PROTEIN KINASE INHIBITORS PHARMASCIENCE, INC. (CA) 2015-07-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150191473-A1 PROTEIN KINASE INHIBITORS TEC, SRC, LCK ALDH1A1 4521/4885SMN1; SMN2 4706/4885MEN1 3741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.